Login
$SKYE
$1.45 -$0.12 (7.64%) Close

$SKYE 4/A SEC Filings

Filed On Filing
28 Feb 2025 Form 4/A: Arsenault Kaitlyn, Chief Financial Officer

Sold 190 shares ($1.05K) · Sold 43,026 shares ($215K)

04 Mar 2024 Form 4/A: Arsenault Kaitlyn, Chief Financial Officer

Received 25,000 shares as a grant or award · Granted 75,000 Stock Option (Right to Buy)

04 Mar 2024 Form 4/A: Dhillon Punit, Director

Received 100,000 shares as a grant or award · Granted 125,000 Stock Option (Right to Buy)

31 Aug 2023 Form 4/A: Dhillon Punit, Director

Acquired 9,000 shares (Small Acquisition) ($106) · Received 20,277,414 shares as a grant or award · Granted 2,253,046 Stock Option (Right to Buy) · 2 more

09 Jan 2023 Form 4/A: Tyle Praveen, Director

Granted 250,000 Stock Option (Right to Buy)

13 Aug 2020 Form 4/A: Emerald Health Sciences Inc., 10% owner

Sold 2,566,666 shares ($257K)

10 Nov 2014 Form 4/A: Mendez Francisco Javier, former Officer, Director, 10%

Disposed of 1,180,000 shares (Other Transaction)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support